Requires health benefits coverage of continuous glucose monitoring systems for treatment of glycogen storage disease.
Impact
If enacted, A3768 would significantly impact healthcare regulations in the state by increasing the obligations of insurers to offer specialized medical technology coverage. This long-awaited change aims to alleviate the financial burden on families affected by glycogen storage disease, providing necessary tools for disease management and better health outcomes. By standardizing coverage requirements across different types of health plans, the bill promotes equitable access to essential healthcare services.
Summary
Assembly Bill A3768 requires health insurers in New Jersey to provide coverage for continuous glucose monitoring systems specifically for patients suffering from glycogen storage disease. This mandate applies to various types of health insurance contracts, including those from health service corporations, medical service corporations, health maintenance organizations, and commercial insurers. The bill ensures that the benefits for continuous glucose monitoring will be covered to the same extent as for any other medical condition under the policy, thereby emphasizing the importance of access to this crucial technology for affected individuals.
Contention
While the intent behind A3768 is to enhance healthcare access for individuals with specific medical needs, there may be contention surrounding the potential increase in insurance premiums resulting from the expanded coverage requirements. Opponents could argue that costs associated with implementing such mandates might be passed on to consumers, making it a point of discussion in the broader context of healthcare reform in New Jersey. Additionally, debates may arise regarding the effectiveness and necessity of such measures within the existing healthcare system.
Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children; requires coverage for glucose monitoring devices for all sugar disorders.
Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children; requires coverage for glucose monitoring devices for all sugar disorders.